deltatrials
Enrolling By Invitation PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT07067177

Prophylactic IV Paracetamol in Extremely Premature Infants

Sponsor: Al-Quds University

Conditions Patent Ductus Arteriosus (PDA) Patent Ductus Arteriosus After Premature Birth Patent Ductus Arteriosus in Premature Infants Patent Ductus Arteriosus in Preterm Infants
Interventions Paracetamol (drug)
Updated 2 times since 2025 Last updated: Jul 5, 2025 Started: May 1, 2025 Primary completion: Oct 1, 2025 Completion: Oct 20, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07067177, this PHASE2/PHASE3 trial focuses on Patent Ductus Arteriosus (PDA) and Patent Ductus Arteriosus After Premature Birth and remains ongoing. Sponsored by Al-Quds University, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshotEnrolling By Invitation~Sep 2025 – present · 11 months · monthly snapshotEnrolling By Invitation

Change History

2 versions recorded

  1. Sep 2025 — Present [monthly]

    Enrolling By Invitation PHASE2/PHASE3

  2. Aug 2025 — Sep 2025 [monthly]

    Enrolling By Invitation PHASE2/PHASE3

    First recorded

May 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Al-Quds University
Data source: Al-Quds University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations